维普中文期刊产品整合服务
178篇 您的检索式:作者名="Hurvitz"
    题名 作者 年代 出处 被引量
1Clinical and laboratory observations of cyclophospha midetherapy inlife-threatenin gvascular tumors显示文摘Hurvitz CH 2007Pediatr2007,109,2:1
2Treatment of a vertebral dissecting aneurysm with stents and coils: technical case report 显示文摘Lylyk P Cemtto R Hurvitz D 1998Neurosurgery1998,43,2:1
3Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in pa- tients with human epidermal growth factor receptor 2-positive meta- static breast cancer显示文摘Hurvitz SA Dirix L Kocsis J 2013J Clin Oncol2013,31,9:1
4Effect of ammonia on the survival and the immune response of rainbow trout ( Oncorhynchus mykiss ) vaccinated against Streptococcus iniae显示文摘HURVITZ A BERCOVIER H RUN J V 1997Fish Shellfish Immunol1997,7,1:1
5Canine hepatic neoplasms: a clinicopathologic study显示文摘Patnaik A K Hurvitz A I Lieberman H 1980Vet Pathol1980,5,:1
6Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hedgkin lymphoma 显示文摘Ansell SM Hurvitz SA Koenig PA 2009Clin Cancer Res2009,15,20:1
7Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver显示文摘Hurvitz SA Hurvitz CH Sloninsky L 0,,:1
8Human epidermal growth factor receptor-2-positive breast cancer:Current management of early,advanced,and recurrent disease 显示文摘Callahan R Hurvitz S 2011Curr Opin Obstet Gynecol2011,23,1:1
9RIBBON-2: a ran- domized, double-blind, placebo-controlled, phase m trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treat- ment of human epidermal growth factor receptor 2-neg- ative metastatic breast cancer 显示文摘Brufsky AM Hurvitz S Perez E 2011J Clin Oncol2011,29,32:1
10Treatment of a vertebral dissecting aneurysm with stents and coils: technical case report显示文摘Lylyk P Ceratto R Hurvitz D 1998Neurosurgery1998,43,:1
11Current options in headend neck reeonstruction显示文摘Hurvitz KA Kobayashi M Evans GR 2006Plast Reconstr Surg2006,118,5:1
12Treatment of a vertebral dissecting anurysm with stents and coils: technical case report 显示文摘Lylyk P Ceratto R Hurvitz D 1998Neurosurgery1998,43,:1
13Phase Q randomized study of tras-tuzumab emtansine versus trastuzumab plus docetaxel in patients withhuman epidermal growth factor receptor 2-positive metastatic breastcancer显示文摘Hurvitz SA Dirix L Kocsis J 2013J Clin 0ncol2013,31,9:1
14Canine hepatic neoplasms:a clinicopathological study显示文摘Patnaik A K Hurvitz A I Lieberman P H 1980Vet Pathol1980,17,:1
15Profiling and targeting HER2-posi-tive breast cancer using trastuzumab emtansine 显示文摘Sadeghi S Olevsky O Hurvitz SA 2014PharmgenomicsPers Med2014,7,:1
16Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia 显示文摘Hurvitz JR Suwairi WM van Hul W 1999Nat Genet1999,23,1:1
17Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma 显示文摘Ansell SM Hurvitz SA Koenig PA 2009Clin Cancer Res2009,15,20:1
18RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative me- tastatic breast cancer 显示文摘Brufsky A M Hurvitz S Perez E 2011J Clin Oncol2011,29,32:1
19Phase M , randomized,double-blind, placebo-controlled study of ribociclib(LEE011) incombination with either tamoxifen and goserelin or a non-steroidalaromatase inhibitor (NSAI) and goserelin for the treatment ofpremenopausal women with HR+, HER2-advanced breast cancer(aBC):MONALEESA-7显示文摘Tripathy D Bardia A Hurvitz S A 2015ASCO Meeting Abstracts2015,33,15:1
20The facioaudio-symphalangism syndrome: report of a case and review of the literature显示文摘 Goodman RM Hertz M 1985Clin Genet1985,28,:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费